Bureau Veritas is a world leader in Testing, Inspection and Certification. Our mission is at the heart of key challenges: quality, health and safety, environmental protection and social responsibility. Through our wide range of expertise, impartiality and independence, we foster confidence between companies, public authorities and clients.
Bureau Veritas is a Business to Business to Society company, contributing to transform the world we live in. Driven by society, we are working ever more closely with our clients, addressing today’s crucial challenges and answering society’s aspirations.
Bureau Veritas is listed on the Euronext Paris (Compartment A, code ISIN FR 0006174348, stock symbol: BVI).
The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, enables customers to accelerate innovation and drug development through patient-centered strategies and data analytics. Our services, which span multiple therapeutic areas, include early development, all phases of clinical development, peri- and post-approval, patient recruitment, investigator sites and comprehensive laboratory services. As a global industry leader, we offer custom solutions to pharma, biotech, medical device, and government organizations, leveraging cutting-edge technology and therapeutic expertise to help customers deliver life-changing therapies.